Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2012
08/08/2012CN101735228B 5-(4-phenoxyacetic acid)-10,15,20-triphenyl zinc porphyrin and preparation method thereof
08/07/2012US8236963 Tricyclic spiro derivatives as CRTH2 modulators
08/07/2012US8236947 Quinoline derivatives and their use as 5-HT6 ligands
08/07/2012US8236841 Fused heterocycle derivative
08/07/2012US8236813 Tricyclic pyrazolopyrimidine derivatives
08/07/2012US8236812 Inhibitors of bruton's tyrosine kinase
08/07/2012US8236809 Substituted 1,2,3-triazolopyrimidines for the inhibition of NAD(P)H oxidases and platelet activation
08/07/2012US8236803 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists
08/07/2012US8236800 antimicrobial agents and antidote for hemorrhagic complications associated with heparin therapy; peptide having optimal sites of polar and nonpolar substituents that confer amphiphilic properties; leucine and aminobenzoic acid derivative; isophthalic acid and diaminobenzene, 3-tert-butyl-6-alkylthio cmpd
08/07/2012CA2412782C Cyclic urea compounds and preparation thereof
08/02/2012WO2012103028A2 Methods and compositions for preparing noribogaine from voacangine
08/02/2012WO2012102387A1 Pyrazole derivative and pest control agent
08/02/2012WO2012101238A1 New pyrimido[5,4-d]pyrimidylamino phenyl sulfonamides as serine/threonine kinase inhibitors
08/02/2012WO2012101197A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
08/02/2012WO2012101032A1 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
08/02/2012WO2012101029A1 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
08/02/2012WO2012100342A1 Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
08/02/2012WO2012076985A3 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
08/02/2012WO2012076973A3 Novel salts of dipeptidyl peptidase iv inhibitor
08/02/2012WO2012075393A3 Activators of proteasomal degradation and uses thereof
08/02/2012WO2009071638A3 Process for the preparation of 2-(primary/secondary amino)hydrocarbyl)- carbamoyl-7-oxo-2,6-diaza-bicyclo[3.2.0.]heptane-6-sulfonic acid derivatives
08/02/2012US20120196880 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
08/02/2012US20120196866 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/02/2012US20120196847 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
08/02/2012US20120196814 (R)-1-(4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY)PROPAN-2-OL METABOLITES
08/02/2012US20120195857 Hepatitis C Virus Inhibitors
08/02/2012CA2825298A1 Methods and compositions for preparing noribogaine from voacangine
08/02/2012CA2825098A1 Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
08/02/2012CA2822120A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
08/01/2012EP2481740A1 Methods and compositions for preparing noribogaine from voacangine
08/01/2012EP2481737A1 Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds
08/01/2012EP2481729A1 Nintrogen-containing bicyclic heteroaryl compounds for the treatment of RAF protein kinase-mediated diseases
08/01/2012EP2481722A1 Sitagliptin intermediates, preparation methods and uses thereof
08/01/2012EP2480554A1 Macrocyclic inhibitors of jak
08/01/2012EP2480553A2 Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
08/01/2012EP2480552A1 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
08/01/2012EP2480551A1 Gpr 119 modulators
08/01/2012EP2480550A1 Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
08/01/2012EP2480549A1 Fused imidazo [3, 2 - d]pyrazines as pi3 kinase inhibitors
08/01/2012EP2480546A1 Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 10a inhibitors
08/01/2012EP2480545A1 Fused triazole amines as p2x7 modulators
08/01/2012EP2480253A1 Adsorption of immunopotentiators to insoluble metal salts
08/01/2012EP2480082A1 Substituted aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
08/01/2012EP2358714B1 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
08/01/2012EP2209784B1 Compounds for the treatment of hepatitis c
08/01/2012EP2163554B1 Pyrimidodiazepinone derivative
08/01/2012EP2142552B1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
08/01/2012EP2121630B1 Fast dissociating dopamine 2 receptor antagonists
08/01/2012EP1819697B1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
08/01/2012EP1405852B1 Diamine derivatives
08/01/2012CN1918137B Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
08/01/2012CN1571788B Photoactivable nitrogen bases
08/01/2012CN102625806A Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/01/2012CN102618075A Zinc phthalocyanine used for high-grade C.I. pigment green 58 and synthesis method thereof
08/01/2012CN102617610A Preparation method of porphyrin photosensitizer and anticarcinogen diad
08/01/2012CN102617581A 58Fe hemin, preparation method and application of 58Fe hemin to study of pharmacokinetics
08/01/2012CN102617580A Vasopressin V1a Antagonists
08/01/2012CN102617579A Preparation method of ibudilast
08/01/2012CN102617578A Imidazole derivative and medicine application thereof
08/01/2012CN102617577A Preparation method of triazolopyrimidine sulfonyl chloride type compound
08/01/2012CN102617576A 7-substituted-phenoxyl-[1,2,4]triazole[4,3-f]pyrimidine derivative used as anti-epileptic drug and medically-usable salt thereof
07/2012
07/31/2012US8232394 Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
07/31/2012US8232393 Aromatic AZA heterocycles, method of production and use of the material in organic electronics
07/31/2012US8232392 Process for preparing temozolomide
07/31/2012US8232291 Heterocyclic aromatic compounds useful as growth hormone secretagogues
07/31/2012US8232286 N-[1-(3-dimethylamino-4-formyl-phenyl)-3-pyridin-3-yl-4,5-dihydro-1H-pyrazolo[4,3-g]benzothiazol-7-yl]-acetamide; phosphatidylinositol-3-kinases (PI3-kinases) inhibitor; cell growth, differentiation and intracellular transport processes; antiproliferative, antiinflammatory agent; autoimmune diseases
07/31/2012US8232280 Inhibitors of bruton'S tyrosine kinase
07/31/2012US8232279 Pyrazolopyrimidine derivatives having biological activity on serotonin receptor 5-HT2c
07/31/2012US8232267 Porphyrin catalysts and methods of use thereof
07/31/2012CA2626700C Pharmaceutical compositions containing erythrina mulungu derivatives, processes for their production and uses thereof
07/31/2012CA2569088C Pyrrolobenzimidazolones and their use as antiproliferative agents
07/31/2012CA2539909C 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo(2,3-c) pyridin-2-ylmethyl) pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes
07/26/2012WO2012100229A2 Compositions and methods for cardiovascular disease
07/26/2012WO2012099454A1 Curcumin compounds and their preparations thereof
07/26/2012WO2012099452A1 Curcumin compounds with superior structural stability and processes for their preparation
07/26/2012WO2012099381A2 Preparation method of intermediate of sitagliptin
07/26/2012WO2012098416A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
07/26/2012WO2012098400A1 Piperazine derivatives as cav2.2 calcium channel blockers
07/26/2012WO2012098068A1 Pyrazolo pyrimidines as dyrk1a and dyrk1b inhibitors
07/26/2012WO2012097750A1 Pyrazolopyrimidinone compound and imidazo-triazone compound for treating erectile dysfunction
07/26/2012WO2012097684A1 Bicyclic carboxamide inhibitors of kinases
07/26/2012WO2012097478A1 Bicyclic carboxamide inhibitors of kinases
07/26/2012WO2012051407A3 Molecular containers and methods of making and using same
07/26/2012WO2012050393A3 Novel compound of a reverse-turn mimetic and a production method and use therefor
07/26/2012WO2012048129A3 Inhibitors of polo-like kinase
07/26/2012US20120190849 Processes for the preparation of vardenafil
07/26/2012US20120190843 Automated radiosynthesis
07/26/2012US20120190842 Process for the preparation of antibiotic compounds
07/26/2012US20120190697 Hiv inhibiting bicyclic pyrimidine derivatives
07/26/2012US20120190696 Inhibitors of fatty acid binding protein (fabp)
07/26/2012US20120190692 Selective substituted pyridine ligands for neuronal nicotinic receptors
07/26/2012US20120190679 Novel Protein Kinase B Inhibitors - 060
07/26/2012US20120190678 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
07/26/2012US20120190673 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
07/26/2012US20120190666 Heteroaryl Compounds as PIKK Inhibitors
07/26/2012US20120190665 Pyrazolopyrimidine jak inhibitor compounds and methods
07/26/2012US20120190639 Treatment or prophylaxis of proliferative conditions
07/26/2012US20120190012 Compositions and methods for dna sequencing
07/26/2012US20120189548 2-arylpyrazolo[l,5-alpha]pyrimidin-3-yl acetamide derivatives as ligands for translocator protein (18 kda)
07/26/2012US20120189547 [18f] labelled analogues of flumazenil as in vivo imaging agents
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 573